Neoadjuvant administration of hydroxychloroquine in a phase 1 clinical trial induced plasma Par-4 levels and apoptosis in diverse tumors

por Wang, Peng, Burikhanov, Ravshan, Jayswal, Rani, Weiss, Heidi L., Arnold, Susanne M., Villano, John L., Rangnekar, Vivek M.
Publicado 2018

Prostate apoptosis response-4 is involved in the apoptosis response to docetaxel in MCF-7 breast cancer cells

por PEREIRA, MICHELLY C., DE BESSA-GARCIA, SIMONE A., BURIKHANOV, RAVSHAN, PAVANELLI, ANA CAROLINA, ANTUNES, LOURIVAL, RANGNEKAR, VIVEK M., NAGAI, MARIA A.
Publicado 2013

Arylquins Target Vimentin to Trigger Par-4 Secretion for Tumor Cell Apoptosis

por Burikhanov, Ravshan, Sviripa, Vitaliy M., Hebbar, Nikhil, Zhang, Wen, Layton, W. John, Hamza, Adel, Zhan, Chang-Guo, Watt, David S., Liu, Chunming, Rangnekar, Vivek M.
Publicado 2014

Chloroquine-Inducible Par-4 Secretion Is Essential for Tumor Cell Apoptosis and Inhibition of Metastasis

por Burikhanov, Ravshan, Hebbar, Nikhil, Noothi, Sunil K., Shukla, Nidhi, Sledziona, James, Araujo, Nathália, Kudrimoti, Meghana, Wang, Qing Jun, Watt, David S., Welch, Danny R., Maranchie, Jodi, Harada, Akihiro, Rangnekar, Vivek M.
Publicado 2017

Tumor Suppressor Par-4 Regulates Complement Factor C3 and Obesity

por Araujo, Nathalia, Sledziona, James, Noothi, Sunil K., Burikhanov, Ravshan, Hebbar, Nikhil, Ganguly, Saptadwipa, Shrestha-Bhattarai, Tripti, Zhu, Beibei, Katz, Wendy S., Zhang, Yi, Taylor, Barry S., Liu, Jinze, Chen, Li, Weiss, Heidi L., He, Daheng, Wang, Chi, Morris, Andrew J., Cassis, Lisa A., Nikolova-Karakashian, Mariana, Nagareddy, Prabhakar R., Melander, Olle, Evers, B. Mark, Kern, Philip A., Rangnekar, Vivek M.
Publicado 2022